Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)

NCT01542736 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Medulloblastoma
High Risk Supratentorial PNET
Metastatic PNET

Interventions

DRUG: Carboplatin
DRUG: Vincristine
RADIATION: 24 Gy

Sponsor

University of Colorado, Denver